Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jillian Haight is active.

Publication


Featured researches published by Jillian Haight.


Nature Genetics | 2001

Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease

Stéphanie A. Backman; Vuk Stambolic; Akira Suzuki; Jillian Haight; Andrew Elia; James Pretorius; Ming-Sound Tsao; Patrick Shannon; Brad Bolon; Gwen O. Ivy; Tak W. Mak

Initially identified in high-grade gliomas, mutations in the PTEN tumor-suppressor are also found in many sporadic cancers and a few related autosomal dominant hamartoma syndromes. PTEN is a 3′-specific phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P3) phosphatase and functions as a negative regulator of PI3K signaling. We generated a tissue-specific deletion of the mouse homolog Pten to address its role in brain function. Mice homozygous for this deletion (PtenloxP/loxP;Gfap-cre), developed seizures and ataxia by 9 wk and died by 29 wk. Histological analysis showed brain enlargement in PtenloxP/loxP;Gfap-cre mice as a consequence of primary granule-cell dysplasia in the cerebellum and dentate gyrus. Pten mutant cells showed a cell-autonomous increase in soma size and elevated phosphorylation of Akt. These data represent the first evidence for the role of Pten and Akt in cell size regulation in mammals and provide an animal model for a human phakomatosis condition, Lhermitte-Duclos disease (LDD).


Nature | 2012

IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics

Masato Sasaki; Christiane B. Knobbe; Joshua Munger; Evan F. Lind; Dirk Brenner; Anne Brüstle; Isaac S. Harris; Roxanne Holmes; Andrew Wakeham; Jillian Haight; Annick You-Ten; Wanda Y. Li; Stefanie Schalm; Shinsan M. Su; Carl Virtanen; Guido Reifenberger; Pamela S. Ohashi; Dwayne L. Barber; Maria E. Figueroa; Ari Melnick; Juan Carlos Zúñiga-Pflücker; Tak W. Mak

Mutations in the IDH1 and IDH2 genes encoding isocitrate dehydrogenases are frequently found in human glioblastomas and cytogenetically normal acute myeloid leukaemias (AML). These alterations are gain-of-function mutations in that they drive the synthesis of the ‘oncometabolite’ R-2-hydroxyglutarate (2HG). It remains unclear how IDH1 and IDH2 mutations modify myeloid cell development and promote leukaemogenesis. Here we report the characterization of conditional knock-in (KI) mice in which the most common IDH1 mutation, IDH1(R132H), is inserted into the endogenous murine Idh1 locus and is expressed in all haematopoietic cells (Vav-KI mice) or specifically in cells of the myeloid lineage (LysM-KI mice). These mutants show increased numbers of early haematopoietic progenitors and develop splenomegaly and anaemia with extramedullary haematopoiesis, suggesting a dysfunctional bone marrow niche. Furthermore, LysM-KI cells have hypermethylated histones and changes to DNA methylation similar to those observed in human IDH1- or IDH2-mutant AML. To our knowledge, our study is the first to describe the generation and characterization of conditional IDH1(R132H)-KI mice, and also the first report to demonstrate the induction of a leukaemic DNA methylation signature in a mouse model. Our report thus sheds light on the mechanistic links between IDH1 mutation and human AML.


Journal of Experimental Medicine | 2009

Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo

Shintaro Kamizono; Gordon S. Duncan; Markus G. Seidel; Akira Morimoto; Koichi Hamada; Gerard Grosveld; Koichi Akashi; Evan F. Lind; Jillian Haight; Pamela S. Ohashi; A. Thomas Look; Tak W. Mak

Nuclear factor interleukin-3 (Nfil3; also known as E4-binding protein 4) is a basic region leucine zipper transcription factor that has antiapoptotic activity in vitro under conditions of growth factor withdrawal. To study the role of Nfil3 in vivo, we generated gene-targeted Nfil3-deficient (Nfil3−/−) mice. Nfil3−/− mice were born at normal Mendelian frequency and were grossly normal and fertile. Although numbers of T cells, B cells, and natural killer (NK) T cells were normal in Nfil3−/− mice, a specific disruption in NK cell development resulted in severely reduced numbers of mature NK cells in the periphery. This defect was NK cell intrinsic in nature, leading to a failure to reject MHC class I–deficient cells in vivo and reductions in both interferon γ production and cytolytic activity in vitro. Our results confirm the specific and essential requirement of Nfil3 for the development of cells of the NK lineage.


Genes & Development | 2012

D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function

Masato Sasaki; Christiane B. Knobbe; Momoe Itsumi; Andrew J. Elia; Isaac S. Harris; Iok In Christine Chio; Rob A. Cairns; Susan McCracken; Andrew Wakeham; Jillian Haight; Annick You Ten; Bryan E. Snow; Takeshi Ueda; Satoshi Inoue; Kazuo Yamamoto; Myunggon Ko; Anjana Rao; Katharine E. Yen; Shinsan M. Su; Tak W. Mak

Isocitrate dehydrogenase-1 (IDH1) R132 mutations occur in glioma, but their physiological significance is unknown. Here we describe the generation and characterization of brain-specific Idh1 R132H conditional knock-in (KI) mice. Idh1 mutation results in hemorrhage and perinatal lethality. Surprisingly, intracellular reactive oxygen species (ROS) are attenuated in Idh1-KI brain cells despite an apparent increase in the NADP(+)/NADPH ratio. Idh1-KI cells also show high levels of D-2-hydroxyglutarate (D2HG) that are associated with inhibited prolyl-hydroxylation of hypoxia-inducible transcription factor-1α (Hif1α) and up-regulated Hif1α target gene transcription. Intriguingly, D2HG also blocks prolyl-hydroxylation of collagen, causing a defect in collagen protein maturation. An endoplasmic reticulum (ER) stress response induced by the accumulation of immature collagens may account for the embryonic lethality of these mutants. Importantly, D2HG-mediated impairment of collagen maturation also led to basement membrane (BM) aberrations that could play a part in glioma progression. Our study presents strong in vivo evidence that the D2HG produced by the mutant Idh1 enzyme is responsible for the above effects.


Immunity | 2008

Fas Receptor Expression in Germinal-Center B Cells Is Essential for T and B Lymphocyte Homeostasis

Zhenyue Hao; Gordon S. Duncan; Jane Seagal; Yu-Wen Su; Claire Hong; Jillian Haight; Nien-Jung Chen; Andrew Elia; Andrew Wakeham; Wanda Y. Li; Jennifer Liepa; Geoffrey A. Wood; Stefano Casola; Klaus Rajewsky; Tak W. Mak

Fas is highly expressed in activated and germinal center (GC) B cells but can potentially be inactivated by misguided somatic hypermutation. We employed conditional Fas-deficient mice to investigate the physiological functions of Fas in various B cell subsets. B cell-specific Fas-deficient mice developed fatal lymphoproliferation due to activation of B cells and T cells. Ablation of Fas specifically in GC B cells reproduced the phenotype, indicating that the lymphoproliferation initiates in the GC environment. B cell-specific Fas-deficient mice also showed an accumulation of IgG1(+) memory B cells expressing high amounts of CD80 and the expansion of CD28-expressing CD4(+) Th cells. Blocking T cell-B cell interaction and GC formation completely prevented the fatal lymphoproliferation. Thus, Fas-mediated selection of GC B cells and the resulting memory B cell compartment is essential for maintaining the homeostasis of both T and B lymphocytes.


Genes & Development | 2013

Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15

Satoshi Inoue; Zhenyue Hao; Andrew J. Elia; David W. Cescon; Lily Zhou; Jennifer Silvester; Bryan E. Snow; Isaac S. Harris; Masato Sasaki; Wanda Y. Li; Momoe Itsumi; Kazuo Yamamoto; Takeshi Ueda; Carmen Dominguez-Brauer; Chiara Gorrini; Iok In Christine Chio; Jillian Haight; Annick You-Ten; Susan McCracken; Andrew Wakeham; Danny Ghazarian; Linda Penn; Gerry Melino; Tak W. Mak

Tumorigenesis results from dysregulation of oncogenes and tumor suppressors that influence cellular proliferation, differentiation, apoptosis, and/or senescence. Many gene products involved in these processes are substrates of the E3 ubiquitin ligase Mule/Huwe1/Arf-BP1 (Mule), but whether Mule acts as an oncogene or tumor suppressor in vivo remains controversial. We generated K14Cre;Mule(flox/flox(y)) (Mule kKO) mice and subjected them to DMBA/PMA-induced skin carcinogenesis, which depends on oncogenic Ras signaling. Mule deficiency resulted in increased penetrance, number, and severity of skin tumors, which could be reversed by concomitant genetic knockout of c-Myc but not by knockout of p53 or p19Arf. Notably, in the absence of Mule, c-Myc/Miz1 transcriptional complexes accumulated, and levels of p21CDKN1A (p21) and p15INK4B (p15) were down-regulated. In vitro, Mule-deficient primary keratinocytes exhibited increased proliferation that could be reversed by Miz1 knockdown. Transfer of Mule-deficient transformed cells to nude mice resulted in enhanced tumor growth that again could be abrogated by Miz1 knockdown. Our data demonstrate in vivo that Mule suppresses Ras-mediated tumorigenesis by preventing an accumulation of c-Myc/Miz1 complexes that mediates p21 and p15 down-regulation.


Cancer Cell | 2016

Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2.

Satoshi Inoue; Wanda Y. Li; Isabel Beerman; Andrew J. Elia; Sean C. Bendall; François Lemonnier; Ken Kron; David W. Cescon; Zhenyue Hao; Evan F. Lind; Naoya Takayama; Aline C. Planello; Shu Yi Shen; Alan H. Shih; Dana M. Larsen; Qinxi Li; Bryan E. Snow; Andrew Wakeham; Jillian Haight; Chiara Gorrini; Christian Bassi; Kelsie L. Thu; Kiichi Murakami; Alisha R. Elford; Takeshi Ueda; Kimberly Straley; Katharine E. Yen; Gerry Melino; Luisa Cimmino; Iannis Aifantis

Mutations in the isocitrate dehydrogenase-1 gene (IDH1) are common drivers of acute myeloid leukemia (AML) but their mechanism is not fully understood. It is thought that IDH1 mutants act by inhibiting TET2 to alter DNA methylation, but there are significant unexplained clinical differences between IDH1- and TET2-mutant diseases. We have discovered that mice expressing endogenous mutant IDH1 have reduced numbers of hematopoietic stem cells (HSCs), in contrast to Tet2 knockout (TET2-KO) mice. Mutant IDH1 downregulates the DNA damage (DD) sensor ATM by altering histone methylation, leading to impaired DNA repair, increased sensitivity to DD, and reduced HSC self-renewal, independent of TET2. ATM expression is also decreased in human IDH1-mutated AML. These findings may have implications for treatment of IDH-mutant leukemia.


Proceedings of the National Academy of Sciences of the United States of America | 2013

Involvement of Toso in activation of monocytes, macrophages, and granulocytes

Karl S. Lang; Philipp A. Lang; Andreas Meryk; Aleksandra A. Pandyra; Louis-Martin Boucher; Vitaly I. Pozdeev; Michael W. Tusche; Joachim R. Göthert; Jillian Haight; Andrew Wakeham; Annick You-Ten; David R. McIlwain; Katja Merches; Vishal Khairnar; Mike Recher; Garry P. Nolan; Yasumichi Hitoshi; Pauline Funkner; Alexander A. Navarini; Admar Verschoor; Namir Shaabani; Nadine Honke; Linda Penn; Pamela S. Ohashi; Dieter Häussinger; Kyeong-Hee Lee; Tak W. Mak

Rapid activation of immune responses is necessary for antibacterial defense, but excessive immune activation can result in life-threatening septic shock. Understanding how these processes are balanced may provide novel therapeutic potential in treating inflammatory disease. Fc receptors are crucial for innate immune activation. However, the role of the putative Fc receptor for IgM, known as Toso/Faim3, has to this point been unclear. In this study, we generated Toso-deficient mice and used them to uncover a critical regulatory function of Toso in innate immune activation. Development of innate immune cells was intact in the absence of Toso, but Toso-deficient neutrophils exhibited more reactive oxygen species production and reduced phagocytosis of pathogens compared with controls. Cytokine production was also decreased in Toso−/− mice compared with WT animals, rendering them resistant to septic shock induced by lipopolysaccharide. However, Toso−/− mice also displayed limited cytokine production after infection with the bacterium Listeria monocytogenes that was correlated with elevated presence of Listeria throughout the body. Accordingly, Toso−/− mice succumbed to infections of L. monocytogenes, whereas WT mice successfully eliminated the infection. Taken together, our data reveal Toso to be a unique regulator of innate immune responses during bacterial infection and septic shock.


Proceedings of the National Academy of Sciences of the United States of America | 2014

TAp73 is required for spermatogenesis and the maintenance of male fertility

Satoshi Inoue; Richard Tomasini; Alessandro Rufini; Andrew J. Elia; Massimiliano Agostini; Ivano Amelio; Dave Cescon; David Dinsdale; Lily Zhou; Isaac S. Harris; Sophie Lac; Jennifer Silvester; Wanda Y. Li; Masato Sasaki; Jillian Haight; Anne Brüstle; Andrew Wakeham; Colin McKerlie; Andrea Jurisicova; Gerry Melino; Tak W. Mak

Significance Defects in spermatogenesis, many of which are unexplained, underlie the infertility problems of ∼20% of couples. Although specific roles for the p53 family members in female fertility have been described, their involvement in spermatogenesis is largely unexpected. Using gene-targeted mice, we have demonstrated that deficiency of TAp73, but not p53 or ∆Np73, leads to male infertility caused by severely impaired germ cell differentiation and maturation to viable sperms in the testes. Importantly, our work has established that TAp73, but not p53, regulates many genes involved in spermatogenesis. Thus, our results provide previously unidentified in vivo evidence that TAp73 is a “guardian” of male germ cells and may point toward a novel avenue for the diagnosis and management of male infertility. The generation of viable sperm proceeds through a series of coordinated steps, including germ cell self-renewal, meiotic recombination, and terminal differentiation into functional spermatozoa. The p53 family of transcription factors, including p53, p63, and p73, are critical for many physiological processes, including female fertility, but little is known about their functions in spermatogenesis. Here, we report that deficiency of the TAp73 isoform, but not p53 or ΔNp73, results in male infertility because of severe impairment of spermatogenesis. Mice lacking TAp73 exhibited increased DNA damage and cell death in spermatogonia, disorganized apical ectoplasmic specialization, malformed spermatids, and marked hyperspermia. We demonstrated that TAp73 regulates the mRNA levels of crucial genes involved in germ stem/progenitor cells (CDKN2B), spermatid maturation/spermiogenesis (metalloproteinase and serine proteinase inhibitors), and steroidogenesis (CYP21A2 and progesterone receptor). These alterations of testicular histology and gene expression patterns were specific to TAp73 null mice and not features of mice lacking p53. Our work provides previously unidentified in vivo evidence that TAp73 has a unique role in spermatogenesis that ensures the maintenance of mitotic cells and normal spermiogenesis. These results may have implications for the diagnosis and management of human male infertility.


Journal of Experimental Medicine | 2012

The E3 ubiquitin ligase Mule acts through the ATM–p53 axis to maintain B lymphocyte homeostasis

Zhenyue Hao; Gordon S. Duncan; Yu-Wen Su; Wanda Y. Li; Jennifer Silvester; Claire Hong; Han You; Dirk Brenner; Chiara Gorrini; Jillian Haight; Andrew Wakeham; Annick You-Ten; Susan McCracken; Andrew Elia; Qinxi Li; Jacqui Detmar; Andrea Jurisicova; Elias Hobeika; Michael Reth; Yi Sheng; Philipp A. Lang; Pamela S. Ohashi; Qing Zhong; Xiaodong Wang; Tak W. Mak

Genetic manipulation reveals that Mule is vital for B cell development, proliferation, and homeostasis as a result of its ability to regulate p53 and ATM.

Collaboration


Dive into the Jillian Haight's collaboration.

Top Co-Authors

Avatar

Tak W. Mak

University Health Network

View shared research outputs
Top Co-Authors

Avatar

Andrew Wakeham

University Health Network

View shared research outputs
Top Co-Authors

Avatar

Andrew J. Elia

University Health Network

View shared research outputs
Top Co-Authors

Avatar

Satoshi Inoue

University Health Network

View shared research outputs
Top Co-Authors

Avatar

Wanda Y. Li

University Health Network

View shared research outputs
Top Co-Authors

Avatar

Annick You-Ten

University Health Network

View shared research outputs
Top Co-Authors

Avatar

Zhenyue Hao

University Health Network

View shared research outputs
Top Co-Authors

Avatar

Masato Sasaki

University Health Network

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Momoe Itsumi

University Health Network

View shared research outputs
Researchain Logo
Decentralizing Knowledge